Therapy candidates chosen for lead projects targeting mast cell driven diseases
Category: Uncategorized
Updated Date: Wed, 22 Mar 2023 00:00:00 EDT
Updated Date: Wed, 22 Mar 2023 00:00:00 EDT
Dr Beatriz Goulao receives more than £500,000 to make trials more patient-focused
Company’s candidate NP137 combined with mFOLFIRINOX will be researched during vital trials
Updated Date: Tue, 21 Mar 2023 00:00:00 EDT
The platform makes it easy to find and apply for jobs in the pharmaceutical and life sciences industry
Clinical trial involves patients with liver cirrhosis and hepatic encephalopathy
MHRA designation involves entry into innovative licensing and access pathway